SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-005782
Filing Date
2024-04-25
Accepted
2024-04-25 16:36:11
Documents
96
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240331x10q.htm   iXBRL 10-Q 2307612
2 EX-10.1 tmb-20240331xex10d1.htm EX-10.1 232715
3 EX-31.1 tmb-20240331xex31d1.htm EX-31.1 10921
4 EX-31.2 tmb-20240331xex31d2.htm EX-31.2 10732
5 EX-32.1 tmb-20240331xex32d1.htm EX-32.1 5933
6 EX-32.2 tmb-20240331xex32d2.htm EX-32.2 6128
7 GRAPHIC tmb-20240331xex10d1001.jpg GRAPHIC 5885
8 GRAPHIC tmb-20240331xex10d1002.jpg GRAPHIC 19533
  Complete submission text file 0001558370-24-005782.txt   12916096

Data Files

Seq Description Document Type Size
9 EX-101.SCH tmb-20240331.xsd EX-101.SCH 83119
10 EX-101.CAL tmb-20240331_cal.xml EX-101.CAL 74972
11 EX-101.DEF tmb-20240331_def.xml EX-101.DEF 410501
12 EX-101.LAB tmb-20240331_lab.xml EX-101.LAB 787446
13 EX-101.PRE tmb-20240331_pre.xml EX-101.PRE 624026
100 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240331x10q_htm.xml XML 2619197
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 24876991
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)